Chitosan functionalized PCL nanoparticles bearing tyrosine kinase inhibitor osimertinib mesylate for effective lung cancer therapy
Anish Dhuri(National Institute of Pharmaceutical Education and Research - Ahmedabad), Pankaj Kumar Singh(Lovely Professional University), Ujala Gupta(National Institute of Pharmaceutical Education and Research (NIPER) - Ahmedabad), Santosh Kumar Guru, Indrani Maji, Mayur Aalhate(National Institute of Pharmaceutical Education and Research - Ahmedabad), Srushti Mahajan, Kishan Kumar Parida(National Institute of Pharmaceutical Education and Research - Ahmedabad), Hoshiyar Singh(National Institute of Pharmaceutical Education and Research), Anitha Sriram(National Institute of Pharmaceutical Education and Research - Ahmedabad)
Cited by 21
Related Papers
Solid self emulsifying drug delivery system: Superior mode for oral delivery of hydrophobic cargos
|Journal of Controlled Release|2021|124
Gold nanoparticles: New routes across old boundaries
|Advances in Colloid and Interface Science|2019|114
Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response
|Journal of Controlled Release|2014|81
Correlation of Particulate Dispersion Stability with the Strength of Self-Assembled Surfactant Films
|Langmuir|2000|79
Fundamental Aspects of Lipid-Based Excipients in Lipid-Based Product Development
|Pharmaceutics|2022|79